AbbVie receives FDA approval for VRAYLAR as adjunctive therapy for MDD
This is the fourth approved indication for VRAYLAR, which has shown improvement in symptoms when used as an…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Dec 22
This is the fourth approved indication for VRAYLAR, which has shown improvement in symptoms when used as an…
16 Dec 22
The approval of the fully human monoclonal antibody in the new indication in the European Union was based…
15 Dec 22
The investment will fast track the development of high-content screening assay services using iCell differentiated induced pluripotent stem…
13 Dec 22
The US health regulator approved the QIAGEN therascreen KRAS RGQ PCR kit as well as the Agilent Resolution…
12 Dec 22
According to Germany-based BioNTech, the combination vaccine candidate is intended to prevent the two respiratory diseases with a…
09 Dec 22
Roche follows global best practices in information security by meeting the stringent criteria set under the ISO 27001…
09 Dec 22
The EUA allows children in the age group of six months to four years to get a primary…
08 Dec 22
The ruling by US District Judge Robin Rosenberg in West Palm Beach, Florida stated that the claims of…
07 Dec 22
Kellogg Company announced today that it has donated 30 million servings of food to Feeding America food banks…
07 Dec 22
The agency is committed to providing a public update on the new vision at the end of January 2023 and…